Download presentation
Presentation is loading. Please wait.
Published bySri Muljana Modified over 5 years ago
1
Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist Fuminori Kimura, M.D., Ph.D., Kentaro Takahashi, M.D., Ph.D., Koichi Takebayashi, M.D., Ph.D., Mutsuko Fujiwara, M.D., Nobuyuki Kita, M.D., Ph.D., Yoichi Noda, M.D., Ph.D., Nobuhiro Harada, Ph.D. Fertility and Sterility Volume 87, Issue 6, Pages 1468.e e12 (June 2007) DOI: /j.fertnstert Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions
2
FIGURE 1 Magnetic resonance images of uterine adenomyosis. All sections are magnetic resonance images of adenomyosis. (A, C) Pretreatment with aromatase inhibitor and GnRH agonist. (B, D) Posttreatment (after 80 d) with aromatase inhibitor and GnRH agonist. (A, B) Sagittal section. (C, D) Axial section. Kimura. Aromatase inhibitor for adenomyosis. Fertil Steril 2007. Fertility and Sterility , 1468.e e12DOI: ( /j.fertnstert ) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.